Who
Christine Mundkur
Director
Company insider
Files Form 4 as: Director, MannKind; Director, Cardinal Health; Chief Executive Officer, Barr Pharmaceuticals.
In numbers
- Trades disclosed
- 38
- Buys
- 1
- Sells
- 0
- Bought
- $75K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 26 Jul 2006
- Last trade
- 20 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 22 May 2026 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —82,781 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —82,781 at $0.00 | filing |
| 5 Nov 2025filed 6 Nov 2025 | CAH Cardinal HealthHealth Care Distribution | SEC FORM 4 Code A | —1,067 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —52,854 at $0.00 | filing |
| 6 Nov 2024filed 7 Nov 2024 | CAH Cardinal HealthHealth Care Distribution | SEC FORM 4 Code A | —1,730 at $0.00 | filing |
| 15 May 2024filed 17 May 2024 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —35,047 at $0.00 | filing |
| 15 Nov 2023filed 16 Nov 2023 | CAH Cardinal HealthHealth Care Distribution | SEC FORM 4 Code A | —1,965 at $0.00 | filing |
| 25 May 2023filed 26 May 2023 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —35,545 at $0.00 | filing |
| 9 Nov 2022filed 10 Nov 2022 | CAH Cardinal HealthHealth Care Distribution | SEC FORM 4 Code A | —2,308 at $0.00 | filing |
| 15 Sep 2022filed 19 Sep 2022 | CAH Cardinal HealthHealth Care Distribution | SEC FORM 4 Code A | —466 at $0.00 | filing |
| 10 May 2022filed 12 May 2022 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —45,045 at $0.00 | filing |
| 28 Feb 2022filed 1 Mar 2022 | MNKD MannKindPharmaceuticals | SEC FORM 4 Bought | $75K27,675 at $2.71 | filing |
| 20 May 2021filed 20 May 2021 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —33,860 at $0.00 | filing |
| 21 May 2020filed 26 May 2020 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —88,235 at $0.00 | filing |
| 14 May 2019filed 16 May 2019 | MNKD MannKindoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —72,115 at $0.00 | filing |
| 20 Feb 2019filed 22 Feb 2019 | MNKD MannKindPharmaceuticals | SEC FORM 4 Code A | —32,608 at $0.00 | filing |
| 23 Dec 2008filed 29 Dec 2008 | Barr Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —42,721 | filing |
| 23 Dec 2008filed 29 Dec 2008 | Barr Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —42,690 | filing |
| 23 Dec 2008filed 29 Dec 2008 | Barr Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —27,144 | filing |
| 23 Dec 2008filed 29 Dec 2008 | Barr Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —27,872 | filing |
News
Comparing MannKind (NASDAQ:MNKD) & Iovance Biotherapeutics (NASDAQ:IOVA)MNKD · tickerreport.com · 15 Oct 2026MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)MNKD · manilatimes.net · 10 Oct 2026
0 headlines in the last 90 days name Christine Mundkur; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.